121. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Immunogenic

BACKGROUND: RSV causes significant disease burden in older adults, since reinfections are common and may lead to severe disease presentations while only supportive treatment is available. We present immunogenicity of different formulations of an investigational vaccine (RSVPreF3) in young and older...

Descripción completa

Detalles Bibliográficos
Autores principales: Guiñazú, Javier Ruiz, Tica, Jelena, Andrews, Charles P, Davis, Matthew G, De Smedt, Philippe, Essink, Brandon, Fogarty, Charles, Kerwin, Edward, Leroux-Roels, Isabel, Vandermeulen, Corinne, David, Marie-Pierre, Dezutter, Nancy, De Schrevel, Nathalie, Fissette, Laurence, Mesaros, Narcisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777862/
http://dx.doi.org/10.1093/ofid/ofaa439.431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777862/
http://dx.doi.org/10.1093/ofid/ofaa439.431

Ejemplares similares